Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

RSS icon

ELCC: Chemo drug increases efficacy of radiotherapy in lung cancer

The phase I trial of the chemotherapy drug pemetrexed (Alimta, Eli Lilly) when used simultaneously with radiotherapy for certain cases of lung cancer has proven to be well-enough tolerated to allow for high dose administration during the treatment, increasing radiotherapys effectiveness,  researchers reported during a presentation at the second annual European Lung Cancer Conference on April 30.

Bristol-Myers sees uptick in Q1, bolstered by strong Plavix sales

Bristol-Myers Squibb (BMS) reported strong sales and earnings growth for the first quarter of 2010.

HSR: Patients under managed care see physicians with worse outcomes

Floridians undergoing PCI and insured by Medicare managed care (MMC) tended to see physicians who had worse reported outcomes compared with patients insured by Medicare fee-for-service, according to a study published in the April issue of Health Services Research.

ASBS: Unsuitable patients may be eligible for accelerated partial breast irradiation

The American Society of Radiology and Oncology (ASTRO) consensus panel guidelines for the application of accelerated partial breast irradiation (APBI), deeming some women unsuitable, does not differentiate a subset of patients with a significantly worse rate of ipsilateral breast tumor recurrence when treated with the MammoSite breast brachytherapy catheter to deliver APBI, said Peter Beitsch, MD, of Dallas Surgical Group in Dallas.

ELCC: Hyperfractionated radiotherapy could improve survival for some

When treated with hyperfractionated or accelerated radiotherapy as opposed to a traditional combined radio-chemotherapy schedule, patients with both non-small-cell lung cancer and small-cell lung cancer benefit in terms of overall survival, according to the results of a meta-analysis presented at the second annual European Lung Cancer Conference (ELCC) last week.

TomoTherapy sees Q1 revenue up, losses down

TomoTherapy has reported a net loss of $4.7 million in the first quarter, which ended March 31, down from the $13 million reported a year ago.

ELCC: New software may bolster breathing-adapted radiotherapy technique

A new 4D software program that combines the breathing-adapted radiotherapy technique will improve the treatment of lung cancer, said Nicolas Peguret, MD, and colleagues from Hpitaux Universitaires de Genve during a presentation at the second annual European Lung Cancer Conference (ELCC) in Geneva last week.

ASTRO: Lung SBRT, a good alternative to surgery for some

According to a recently released report by the American Society for Radiation Oncology (ASTRO), stereotactic body radiotherapy (SBRT) in the treatment of lung cancer can be a reasonable alternative to surgery in certain cases of the disease.

Displaying 1769 - 1776 of 2553

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.